PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES OF CENTRALLY ACTING DRUGSIN RAT - EFFECT OF PENTOBARBITAL AND CHLORPROMAZINE ON ELECTROENCEPHALOGRAM IN RAT
S. Sato et al., PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES OF CENTRALLY ACTING DRUGSIN RAT - EFFECT OF PENTOBARBITAL AND CHLORPROMAZINE ON ELECTROENCEPHALOGRAM IN RAT, Biological & pharmaceutical bulletin, 18(8), 1995, pp. 1094-1103
Electroencephalogram (EEG) alterations in rat after the i.v. administr
ation of pentobarbital (PTB) and chlorpromazine (CPZ) were measured by
power spectral analysis. The time courses of PTB concentrations in pl
asma, cerebrospinal fluid (CSF) and brain were determined after the i.
v. administration of PTB (20, 40 mg/kg) by GC-MS. The PTB concentratio
ns in plasma, CSF and brain could be described by a biexponential equa
tion, a CSF model and a blood flow limited model, respectively. The re
lationship between the alteration of EEG and the PTB concentrations in
the CSF or brain or the effect compartment were analyzed using the si
gmoid E(max) model. The alteration of EEG after PTB administration cou
ld be described by the PTB concentration in these compartments using t
he sigmoid E(max) model. These results indicated that the site of acti
on for the alteration of EEG after PTB administration is in instantane
ous equilibrium with the CSF, the brain and the effect compartment. Th
us, alterations in EEG after PTB administration can be predicted by mo
nitoring the total PTB concentration in plasma. The alteration of EEG
after i.v. administration of CPZ (4 mg/kg) showed a two-phase variatio
n. Although the relationship between the alteration of EEG and the CPZ
concentrations in CSF or the striatum or the effect compartment (tota
l and free drug) were analyzed using the linear model, the E(max) mode
l or the sigmoid E(max) model, the two-phase alteration of EEG after C
PZ administration could not be described by any of these models. These
results indicated that the pharmacokinetic and pharmacodynamic modeli
ng of CPZ during the alteration of EEC may be complicated due to sever
al pharmacokinetic and pharmacodynamic factors, such as an alteration
of the free fraction of CPZ in the striatum, the formation of active m
etabolites, and two different intrinsic effects of CPZ on the EEG (one
in an increase and the other in a decrease of the brain's electrical
activity).